Antibody therapies have been a key tool in keeping patients out of hospitals, but drug companies are fighting to stay ahead of coronavirus mutations.
Antibody therapies have been a key tool in keeping patients out of hospitals, but drug companies are fighting to stay ahead of coronavirus mutations.